← Leaderboards
John V Williams
Vanderbilt University
$14,790,794
Attributed
$22,120,193
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$14,658,798 · 2
NIH$7,461,395 · 8
By mechanism
U01$14,658,798 · 2
R01$5,191,494 · 1
R21$1,685,751 · 4
K08$357,858 · 1
R03$226,292 · 2
Top collaborators
- Marian G Michaels12 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Terence S. Dermody$49,981,852
- Jessalyn J Baljon$119,772
- Helen Keipp Talbot$7,247,906
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildVaccinesHuman MetapneumovirusInfectionParamyxovirusRespiratory Syncytial VirusLifePersonsAsthmaViralVirusPathogenesisPathogenAdultImmuneImmunityMediatingLower Respiratory Tract InfectionResponseRespiratory VirusCellsLungImmunopathologyExhibits
Grant awards (42)
Host Determinants of Human Metapneumovirus Immunity and Pathogenesis$460,367
R01 · FY2025 · AI · contact PI
Discovery of human metapneumovirus epitopes$233,250
R21 · FY2025 · AI · contact PI
Host Determinants of Human Metapneumovirus Immunity and Pathogenesis$466,434
R01 · FY2024 · AI · contact PI
Discovery of human metapneumovirus epitopes$174,938
R21 · FY2024 · AI · contact PI
Discovery of human metapneumovirus epitopes$1,282
R21 · FY2024 · AI · contact PI
IP21-002, New Vaccine Surveillance Network$2,750,000
U01 · FY2023 · IP · contact PI
IP21-002, New Vaccine Surveillance Network$2,300,000
U01 · FY2023 · IP · contact PI
Host Determinants of Human Metapneumovirus Immunity and Pathogenesis$466,306
R01 · FY2023 · AI · contact PI
IP21-002, New Vaccine Surveillance Network$1,924,241
U01 · FY2022 · IP · contact PI
IP21-002, New Vaccine Surveillance Network$1,402,123
U01 · FY2021 · IP · contact PI
New Vaccine Surveillance Network$1,505,484
U01 · FY2020 · IP · contact PI
Host Determinants of Human Metapneumovirus and Pathogenesis$377,169
R01 · FY2020 · AI · contact PI
New Vaccine Surveillance Network SUPPLEMENT$1,000,000
U01 · FY2019 · IP · contact PI
Host Determinants of Human Metapneumovirus and Pathogenesis$377,418
R01 · FY2019 · AI · contact PI
New Vaccine Surveillance Network$300,000
U01 · FY2019 · IP · contact PI
New Vaccine Surveillance Network$1,226,950
U01 · FY2018 · IP · contact PI
Host Determinants of Human Metapneumovirus and Pathogenesis$377,480
R01 · FY2018 · AI · contact PI
New Vaccine Surveillance Network$250,000
U01 · FY2018 · IP · contact PI
New Vaccine Surveillance Network$1,000,000
U01 · FY2017 · IP · contact PI
Host Determinants of Human Metapneumovirus and Pathogenesis$380,593
R01 · FY2017 · AI · contact PI
New Vaccine Surveillance Network$785,715
U01 · FY2016 · IP · contact PI
Host Determinants of Human Metapneumovirus and Pathogenesis$381,207
R01 · FY2016 · AI · contact PI
New Vaccine Surveillance Network$214,285
U01 · FY2016 · IP · contact PI
High-throughput Screening for Inhibitors of Human Metapneumovirus$139,558
R21 · FY2015 · AI · contact PI
High-throughput Screening for Inhibitors of Human Metapneumovirus$53,973
R21 · FY2015 · AI · contact PI
Host determinants of human metapneumovirus immunity and pathogenesis$323,029
R01 · FY2014 · AI · contact PI
High-throughput Screening for Inhibitors of Human Metapneumovirus$234,750
R21 · FY2014 · AI · contact PI
Host Determinants of Human Metapneumovirus Immunity and Pathogenesis$59,063
R01 · FY2014 · AI · contact PI
Host determinants of human metapneumovirus immunity and pathogenesis$362,934
R01 · FY2013 · AI · contact PI
Host determinants of human metapneumovirus immunity and pathogenesis$386,100
R01 · FY2012 · AI · contact PI
Host determinants of human metapneumovirus immunity and pathogenesis$385,894
R01 · FY2011 · AI · contact PI
Host determinants of human metapneumovirus immunity and pathogenesis$387,500
R01 · FY2010 · AI · contact PI
Attenuated Strains of Human Metapneumovirus for Vaccines and Pathogenesis$193,750
R21 · FY2010 · AI · contact PI
Attenuated Strains of Human Metapneumovirus for Vaccines and Pathogenesis$232,125
R21 · FY2009 · AI · contact PI
Cell Entry of Human Metapneumovirus$191,875
R21 · FY2009 · AI · contact PI
Cell Entry of Human Metapneumovirus$230,250
R21 · FY2008 · AI · contact PI
Epidemiology and Clinical Features of Human Coronavirus$75,292
R03 · FY2008 · AI · contact PI
Determinanats of Protective Immunity to Metapneumovirus$119,286
K08 · FY2005 · AI
Determinanats of Protective Immunity to Metapneumovirus$119,286
K08 · FY2004 · AI
Human Metapneumovirus Infections in Children$75,500
R03 · FY2004 · AI
Determinanats of Protective Immunity to Metapneumovirus$119,286
K08 · FY2003 · AI
Human Metapneumovirus Infections in Children$75,500
R03 · FY2003 · AI